These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6127069)

  • 1. Loss of hypothalamic dopaminergic control of prolactin secretion in the hyperprolactinaemic rat.
    Smythe GA; Bradshaw JE; Duncan M
    Aust J Biol Sci; 1982; 35(2):207-13. PubMed ID: 6127069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained oestrogen-induced hyperprolactinaemia results from a pituitary defect.
    Willoughby JO; Pederick HJ; Jervois PM; Menadue MF
    J Endocrinol; 1983 Dec; 99(3):477-83. PubMed ID: 6196429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-methyl-D-aspartic acid and kainic acid on prolactin secretion in hyper- and hypoprolactinaemic conditions.
    Pinilla L; Tena-Sempere M; Aguilar R; Aguilar E
    Eur J Endocrinol; 1998 Apr; 138(4):460-6. PubMed ID: 9578517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different acute effects of the tyrosine hydroxylase inhibitors alpha-methyl-p-tyrosine and 3-iodo-L-tyrosine on hypothalamic noradrenaline activity and adrenocorticotrophin release in the rat.
    Smythe GA; Bradshaw JE
    Aust J Biol Sci; 1983; 36(5-6):519-23. PubMed ID: 6144300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic tyrosine hydroxylase activity and plasma gonadotropin and prolactin levels in ovariectomized-steroid treated rats.
    Babu GN; Vijayan E
    Brain Res Bull; 1984 May; 12(5):555-8. PubMed ID: 6147181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):53-63. PubMed ID: 6420095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinaemia and DNA synthesis in the pituitary gland of the rat.
    Burdman JA; Calabrese MT; MacLeod RM
    J Endocrinol; 1983 Apr; 97(1):65-74. PubMed ID: 6132955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion.
    Ferland L; Labrie F; Kelly PA; Raymond V
    Fed Proc; 1980 Sep; 39(11):2917-22. PubMed ID: 7409210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats.
    Fernández-Ruiz JJ; Alvarez-Sanz C; Ramos JA
    J Steroid Biochem; 1989 Jan; 32(1A):71-5. PubMed ID: 2536446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lead treatment affects dopaminergic control of prolactin secretion in rat pituitary.
    Govoni S; Lucchi L; Battaini F; Spano PF; Trabucchi M
    Toxicol Lett; 1984 Mar; 20(3):237-41. PubMed ID: 6701910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple procedure for the assay of brain biogenic amines by selected-ion monitoring: its application to the elucidation of the mechanism of prolactin release induced by 3-iodo-L-tyrosine.
    Smythe GA; Brandstater JF; Bradshaw JE; Lazarus L
    Aust J Biol Sci; 1979 Jun; 32(3):335-41. PubMed ID: 508206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
    Soaje M; Valdez S; Bregonzio C; Penissi A; Deis RP
    Neuroendocrinology; 2006; 84(1):58-67. PubMed ID: 17090971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic dopamine and catechol oestrogens in rats with spontaneous pituitary tumours.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    J Endocrinol; 1983 Feb; 96(2):347-52. PubMed ID: 6131099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
    Krulich L; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Neuroendocrinology; 1980; 30(3):133-8. PubMed ID: 6445044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of prolactin secretion by 3-iodo-L-tyrosine.
    Smythe GA; Brandstater JF; Lazarus L
    Neuroendocrinology; 1974; 14(6):362-4. PubMed ID: 4153459
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of time of day on hypothalamic monoaminergic activity in early pregnancy: effect of a previous reproductive experience.
    Sider LH; Hucke EE; Florio JC; Felicio LF
    Psychoneuroendocrinology; 2003 Feb; 28(2):195-206. PubMed ID: 12510012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.